$2.290
-0.030 (-1.29%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PRQR Prediction & Forecast by Similar Chart Analysis
Alphio's PRQR stock price prediction model matches the current ProQR Therapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.27 (-0.66%). The 1-week path is $2.39 (+4.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ProQR Therapeutics NV Stock?
ProQR Therapeutics is a good buy right now, trading at $2.29 with a recent analyst price target of $8 from BofA, indicating a potential upside of over 250%. Additionally, the stock has a strong RSI of 60.6, suggesting it is not overbought. The main risk is the negative net income of -13,383,000 EUR in Q1 2026, which reflects ongoing financial challenges.
PRQR stock price ended at $2.29 on Friday, after losing -1.29%
ProQR Therapeutics NV (PRQR) last closed at $2.29, losing -1.29%. These facts feed the 1-day and 1-week PRQR price prediction above.
Analyst Consensus
ProQR Therapeutics NV (PRQR): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
ProQR Therapeutics NV (PRQR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches PRQR, ranked by similarity.
Seasonality analysis for PRQR
Historically the probability of a positive August return for PRQR is 26.98%. November offers the highest probability of a positive month at 51.28%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PRQR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.04 | $2.54 | $3.42 | +10.70% |
| Sep 2026 | $2.35 | $2.65 | $2.79 | +15.52% |
| Oct 2026 | $1.48 | $1.82 | $2.73 | -20.71% |
| Nov 2026 | $1.23 | $2.01 | $2.85 | -12.02% |
| Dec 2026 | $1.58 | $1.82 | $2.08 | -20.71% |
In 2026, ProQR Therapeutics NV (PRQR) is projected to range from $1.23 to $3.42.
ProQR Therapeutics NV 2026 monthly forecast
In Aug 2026, ProQR Therapeutics NV is projected to average $2.54, with a low of $2.04 and high of $3.42.
In Sep 2026, ProQR Therapeutics NV is projected to average $2.65, with a low of $2.35 and high of $2.79.
In Oct 2026, ProQR Therapeutics NV is projected to average $1.82, with a low of $1.48 and high of $2.73.
In Nov 2026, ProQR Therapeutics NV is projected to average $2.01, with a low of $1.23 and high of $2.85.
In Dec 2026, ProQR Therapeutics NV is projected to average $1.82, with a low of $1.58 and high of $2.08.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.